{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Horseheads",
      "state": "NY",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "77834",
      "recalling_firm": "X-Gen Pharmaceuticals Inc.",
      "address_1": "300 Daniel Zenker Dr",
      "address_2": "N/A",
      "postal_code": "14845-1014",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide in the US",
      "recall_number": "D-1059-2017",
      "product_description": "Nystatin Topical Powder, USP, 100,000 USP units per gram, 15 grams per bottle, Rx only, Vensun, NDC 42543-052-61",
      "product_quantity": "9,816 bottles",
      "reason_for_recall": "Presence of Foreign Substance:  potential presence of plastic particles.",
      "recall_initiation_date": "20170517",
      "center_classification_date": "20170809",
      "termination_date": "20180905",
      "report_date": "20170816",
      "code_info": "Lot #: 23701.158A, EXP 10/31/18"
    }
  ]
}